Whistleblower Claims Over Lipitor Marketing Tossed

Law360, New York (May 27, 2009, 12:00 AM EDT) -- A federal judge has dismissed whistleblower claims filed by a former medical director at Pfizer Inc. over the company's alleged off-label marketing of its statin Lipitor, but has allowed the doctor's claims for retaliation to go forward.

Judge Edward R. Korman of the U.S. District Court for the Eastern District of New York ruled Friday that Dr. Jesse Polansky, who was Pfizer's director of outcome management strategies from 2001 until he was terminated in 2003, had not alleged any particular false statements made by Pfizer to...
To view the full article, register now.